Literature DB >> 25541739

Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants.

Clovis Arcoverde Freitas-Neto1,2,3, Armin Maghsoudlou1,2, Swetha Dhanireddy1,2, Abhishek Payal1,2, Sutasinee Boonsopon1,2, Malinga D Ratwatte1,2, C Stephen Foster1,2,4.   

Abstract

PURPOSE: To evaluate outcomes of long-term follow-up of Retisert multiple implantation and dissociation in eyes with chronic noninfectious uveitis.
METHODS: Review of 187 consecutive Retisert implants. Outcomes of multiple implantation and spontaneous medication pellet-strut dissociation were evaluated.
RESULTS: A total of 187 consecutive Retisert implants were reviewed. Eight implants were removed. The prevalence of spontaneous dissociation was 2.6% (5/187). The rate of dissociation increased to 11.11% (2/18) in cases of multiple implants. The mean period between Retisert implantation and spontaneous dissociation was 65.05 months. The mean period between implants in the same eye was 55.25 months. In cases of multiple implantations the old implant was not removed and 17.64% (3/17) of eyes required glaucoma filtering surgery.
CONCLUSION: The rate of spontaneous dissociation of Retisert medication pellet-strut in eyes with single implant for noninfectious uveitis is low, which tends to increase in eyes with multiple implants.

Entities:  

Keywords:  Chronic noninfectious uveitis; fluocinolone acetonide implant; implant dissociation; multiple implant; retisert

Mesh:

Substances:

Year:  2014        PMID: 25541739     DOI: 10.3109/09273948.2014.986583

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Fluocinolone Implant Forceps: Instrument Modification for Enhanced Implant Insertion.

Authors:  Samuel Burke; Thomas A Albini; Juan D Silgado; Basil K Williams; Jean-Marie A Parel
Journal:  Int Ophthalmol Clin       Date:  2016

2.  Noninvasive monitoring of suprachoroidal, subretinal, and intravitreal implants using confocal scanning laser ophthalmoscope (cSLO) and optical coherence tomography (OCT).

Authors:  Madhoosudan A Patil; Uday B Kompella
Journal:  Int J Pharm       Date:  2021-07-14       Impact factor: 6.510

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.